• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型隐球菌抗原的血清学、电泳及生物学特性

Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens.

作者信息

Murphy J W, Mosley R L, Cherniak R, Reyes G H, Kozel T R, Reiss E

机构信息

Department of Botany-Microbiology, University of Oklahoma, Norman 73019.

出版信息

Infect Immun. 1988 Feb;56(2):424-31. doi: 10.1128/iai.56.2.424-431.1988.

DOI:10.1128/iai.56.2.424-431.1988
PMID:3123390
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC259299/
Abstract

We compared a cryptococcal culture filtrate antigen referred to as CneF with chemically defined cryptococcal antigen fractions isolated by Cherniak and co-workers by using double immunodiffusion gels, polyacrylamide gel electrophoresis, immunoblots, and footpad reactivity of immunized mice. The three previously described components of cryptococcal culture filtrates are a high-molecular-weight glucuronoxylo-mannan (GXM), which is the major constituent, a galactoxylomannan (GaIXM), and a mannoprotein (MP). In this study we demonstrated that CneF contained components which were serologically and electrophoretically similar to the three previously described cryptococcal culture filtrate fractions. The MP fraction elicited significantly stronger delayed-type hypersensitivity responses than did the GXM or GaIXM fraction when used in mice immunized either with the CneF in complete Freund adjuvant or whole heat-killed Cryptococcus neoformans yeast cells. These findings were confirmed when the footpads of immunized mice were challenged with GaIXM and MP preparations from a culture filtrate of a C. neoformans acapsular mutant that does not produce GXM. Thus, we concluded that the MP was the primary component recognized by the anticryptococcal cell-mediated immune response in mice.

摘要

我们使用双免疫扩散凝胶、聚丙烯酰胺凝胶电泳、免疫印迹以及免疫小鼠的足垫反应性,将一种名为CneF的隐球菌培养滤液抗原与Cherniak及其同事分离得到的化学定义的隐球菌抗原组分进行了比较。隐球菌培养滤液先前描述的三种成分是高分子量葡糖醛酸木聚糖甘露聚糖(GXM),它是主要成分,半乳糖木聚糖甘露聚糖(GaIXM)和甘露糖蛋白(MP)。在本研究中,我们证明CneF所含的成分在血清学和电泳方面与先前描述的三种隐球菌培养滤液组分相似。当用完全弗氏佐剂中的CneF或全热灭活的新型隐球菌酵母细胞免疫小鼠时,MP组分引发的迟发型超敏反应比GXM或GaIXM组分明显更强。当用来自不产生GXM的新型隐球菌无荚膜突变体培养滤液的GaIXM和MP制剂攻击免疫小鼠的足垫时,这些发现得到了证实。因此,我们得出结论,MP是小鼠抗隐球菌细胞介导的免疫反应识别的主要成分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b64/259299/e76167a445b7/iai00074-0145-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b64/259299/8a37b583c506/iai00074-0142-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b64/259299/ddffbae3a8cf/iai00074-0143-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b64/259299/5accdcdd61b4/iai00074-0144-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b64/259299/e76167a445b7/iai00074-0145-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b64/259299/8a37b583c506/iai00074-0142-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b64/259299/ddffbae3a8cf/iai00074-0143-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b64/259299/5accdcdd61b4/iai00074-0144-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b64/259299/e76167a445b7/iai00074-0145-a.jpg

相似文献

1
Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens.新型隐球菌抗原的血清学、电泳及生物学特性
Infect Immun. 1988 Feb;56(2):424-31. doi: 10.1128/iai.56.2.424-431.1988.
2
Effects of immunization with Cryptococcus neoformans cells or cryptococcal culture filtrate antigen on direct anticryptococcal activities of murine T lymphocytes.用新型隐球菌细胞或隐球菌培养滤液抗原进行免疫对小鼠T淋巴细胞直接抗隐球菌活性的影响。
Infect Immun. 1995 May;63(5):1645-51. doi: 10.1128/iai.63.5.1645-1651.1995.
3
Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen.人类中性粒细胞对新型隐球菌细胞、培养滤液抗原及该抗原各成分的反应性迁移
Infect Immun. 1993 Dec;61(12):5067-77. doi: 10.1128/iai.61.12.5067-5077.1993.
4
Characterization of a third-order suppressor T cell (Ts3) induced by cryptococcal antigen(s).由隐球菌抗原诱导产生的三阶抑制性T细胞(Ts3)的特性
Infect Immun. 1987 Jul;55(7):1657-62. doi: 10.1128/iai.55.7.1657-1662.1987.
5
Immunoadsorption of Cryptococcus-specific suppressor T-cell factors.隐球菌特异性抑制性T细胞因子的免疫吸附
Infect Immun. 1986 Mar;51(3):844-50. doi: 10.1128/iai.51.3.844-850.1986.
6
Isolation and purification of antigenic components of Cryptococcus.新型隐球菌抗原成分的分离与纯化。
Methods Mol Biol. 2009;470:71-83. doi: 10.1007/978-1-59745-204-5_7.
7
An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannan.一种针对半乳甘露聚糖的抗新型隐球菌单克隆抗体。
Res Immunol. 1990 Jan;141(1):33-42. doi: 10.1016/0923-2494(90)90099-k.
8
The Cryptococcus neoformans gene DHA1 encodes an antigen that elicits a delayed-type hypersensitivity reaction in immune mice.新型隐球菌基因DHA1编码一种抗原,该抗原能在免疫小鼠中引发迟发型超敏反应。
Infect Immun. 2000 Nov;68(11):6196-201. doi: 10.1128/IAI.68.11.6196-6201.2000.
9
Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies.用单克隆抗体对新型隐球菌荚膜葡糖醛酸木聚糖甘露聚糖多糖进行表征。
Infect Immun. 1989 Dec;57(12):3882-7. doi: 10.1128/iai.57.12.3882-3887.1989.
10
Influence of cryptococcal antigens on cell-mediated immunity.隐球菌抗原对细胞介导免疫的影响。
Rev Infect Dis. 1988 Jul-Aug;10 Suppl 2:S432-5. doi: 10.1093/cid/10.supplement_2.s432.

引用本文的文献

1
Identification of a protective antigen reveals the trade-off between iron acquisition and antigen exposure in a global fungal pathogen.一种保护性抗原的鉴定揭示了一种全球真菌病原体在获取铁和暴露抗原之间的权衡。
Proc Natl Acad Sci U S A. 2025 Feb 18;122(7):e2420898122. doi: 10.1073/pnas.2420898122. Epub 2025 Feb 13.
2
Dendritic Cells: Multifunctional Roles in Host Defenses to Infections.树突状细胞:在宿主抗感染防御中的多功能作用
J Fungi (Basel). 2023 Oct 26;9(11):1050. doi: 10.3390/jof9111050.
3
Immunoprotection against Cryptococcosis Offered by Znf2 Depends on Capsule and the Hyphal Morphology.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
The antigenic composition of Cryptococcus neoformans. II. Serologic studies with the capsular polysaccharide.新型隐球菌的抗原组成。II. 荚膜多糖的血清学研究
J Immunol. 1951 Aug;67(2):109-14.
3
Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans.新型隐球菌荚膜突变体的遗传与表型特征分析
锌指蛋白 2 介导的免疫保护作用依赖于荚膜和菌丝形态。
mBio. 2022 Feb 22;13(1):e0278521. doi: 10.1128/mbio.02785-21. Epub 2022 Jan 11.
4
Basic principles of the virulence of .的毒力的基本原则。
Virulence. 2019 Dec;10(1):490-501. doi: 10.1080/21505594.2019.1614383.
5
Titan cell production in reshapes the cell wall and capsule composition during infection.感染期间巨细胞的产生重塑了细胞壁和荚膜成分。
Cell Surf. 2018 Mar;1:15-24. doi: 10.1016/j.tcsw.2017.12.001. Epub 2018 Feb 16.
6
A Call to Arms: Quest for a Cryptococcal Vaccine.《行动呼吁:寻找隐球菌疫苗》
Trends Microbiol. 2018 May;26(5):436-446. doi: 10.1016/j.tim.2017.10.002. Epub 2017 Nov 2.
7
Capsule Enlargement in Is Dependent on Mitochondrial Activity.荚膜增大取决于线粒体活性。
Front Microbiol. 2017 Jul 31;8:1423. doi: 10.3389/fmicb.2017.01423. eCollection 2017.
8
Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.用含新型隐球菌碱性提取物的葡聚糖颗粒接种后对实验性隐球菌病的保护作用。
mBio. 2015 Dec 22;6(6):e01905-15. doi: 10.1128/mBio.01905-15.
9
Cryptococcus neoformans host adaptation: toward biological evidence of dormancy.新型隐球菌的宿主适应性:迈向休眠的生物学证据
mBio. 2015 Mar 31;6(2):e02580-14. doi: 10.1128/mBio.02580-14.
10
Exploiting fungal cell wall components in vaccines.在疫苗中利用真菌细胞壁成分。
Semin Immunopathol. 2015 Mar;37(2):199-207. doi: 10.1007/s00281-014-0460-6. Epub 2014 Nov 18.
J Bacteriol. 1982 Jun;150(3):1292-6. doi: 10.1128/jb.150.3.1292-1296.1982.
4
Cryptococcal skin test antigen: preparation variables and characterization.隐球菌皮肤试验抗原:制备变量与特性
Infect Immun. 1981 Apr;32(1):373-80. doi: 10.1128/iai.32.1.373-380.1981.
5
Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A.新型隐球菌A血清型荚膜多糖的结构与抗原活性
Mol Immunol. 1980 Aug;17(8):1025-32. doi: 10.1016/0161-5890(80)90096-6.
6
Decreased virulence in stable, acapsular mutants of cryptococcus neoformans.新型隐球菌稳定无荚膜突变体的毒力降低。
Mycopathologia. 1982 Jul 23;79(1):23-9. doi: 10.1007/BF00636177.
7
Enzyme immunoassay detection of IgM to galactoxylomannan of Cryptococcus neoformans.酶免疫法检测新型隐球菌半乳甘露聚糖的IgM
Diagn Immunol. 1984;2(2):109-15.
8
Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans.新型隐球菌半乳甘露聚糖的分级分离与特性分析
Carbohydr Res. 1984 Feb 15;125(2):343-9. doi: 10.1016/0008-6215(84)85172-1.
9
Anticryptococcal type D antibodies raised in rabbits.在兔体内产生的抗新型隐球菌D型抗体。
Mol Immunol. 1983 Apr;20(4):351-9. doi: 10.1016/0161-5890(83)90016-0.
10
Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates.新型隐球菌血清型的抗原特性及其在临床分离株血清分型中的应用。
J Clin Microbiol. 1982 Jul;16(1):22-9. doi: 10.1128/jcm.16.1.22-29.1982.